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Abstract
Background: Gene expression studies can be used to help identify disease-associated genes by comparing the
levels of expressed transcripts between cases and controls, and to identify functional genetic variants (expression
quantitative loci or eQTLs) by comparing expression levels between individuals with different genotypes. While
many of these studies are performed in blood or lymphoblastoid cell lines due to tissue accessibility, the relevance
of expression differences in tissues that are not the primary site of disease is unclear. Further, many eQTLs are
tissue specific. Thus, there is a clear and compelling need to conduct gene expression studies in tissues that are
specifically relevant to the disease of interest. One major technical concern about using autopsy-derived tissue is
how representative it is of physiologic conditions, given the effect of postmortem interval on tissue degradation.
Results: In this study, we monitored the gene expression of 13 tissue samples harvested from a rapid autopsy
heart (non-failed heart) and 7 from a cardiac explant (failed heart) through 24 hours of autolysis. The 24 hour
autopsy simulation was designed to reflect a typical autopsy scenario where a body may begin cooling to ambient
temperature for ~12 hours, before transportation and storage in a refrigerated room in a morgue. In addition, we
also simulated a scenario wherein the body was left at room temperature for up to 24 hours before being found.
A small fraction (< 2.5%) of genes showed fluctuations in expression over the 24 hr period and largely belong to
immune and signal response and energy metabolism-related processes. Global expression analysis suggests that
RNA expression is reproducible over 24 hours of autolysis with 95% genes showing < 1.2 fold change. Comparing
the rapid autopsy to the failed heart identified 480 differentially expressed genes, including several types of
collagens, lumican (LUM), natriuretic peptide A (NPPA) and connective tissue growth factor (CTGF), which allows for
the clear separation between failing and non-failing heart based on gene expression profiles.
Conclusions: Our results demonstrate that RNA from autopsy-derived tissue, even up to 24 hours of autolysis, can
be used to identify biologically relevant expression pattern differences, thus serving as a practical source for gene
expression experiments.
Background
Gene expression studies monitor the simultaneous tran-
scription levels of genes, and thus bridge the gap between
static genomic information and dynamic phenotypes.
These studies are used to identify differentially expressed
transcripts with respect to measured variables of interest,
such as differing environments, treatments, phenotypes,
or clinical outcomes, and for the identification of expres-
sion quantitative trait loci (eQTL), i.e. genomic regions
whose genotype is correlated with the RNA expression in
a panel of genetically diverse individuals [1]. Studies of
gene expression abnormalities in various disorders often
i n v o l v et h eu s eo fp o s t m o r t e mt i s s u e[ 2 ] .T h ef a c t o r s
affecting RNA stability or integrity in postmortem tissues
have been most extensively studied in the neuropsychia-
tric area. Despite the success with identification of sets of
differentially expressed genes specific to neuropsychiatric
disorders, one can find continued concerns regarding
quality and consistency of postmortem RNA analysis [3].
Prior studies in brain have indicated that specific agonal
factors, including coma and hypoxia, markedly affect
the integrity of RNA, whereas postmortem factors have
relatively minor effects on RNA integrity [4]. Of the
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tance for RNA quality in some publications [5].
Recent studies in human skeletal and heart tissues pro-
vide examples of variation in protein and enzyme activity,
with examples of reduced NOS3 mRNA levels associated
with higher postmortem interval (PMI) [6]. These altera-
tions appear to occur more rapidly at higher tempera-
tures, and storing samples at 4°C may delay some of the
postmortem changes [7]. There has been a lingering
debate over the importance of PMI on RNA degradation.
Thus, in addition to variation in expression levels due to
technical [8], environmental [9], demographic [10], and
genetic factors [11], concerns arise as RNA integrity is
affected by various pre- and postmortem events [12],
which need to be addressed when quantitative analyses
are performed.
These sources of variation raise a major technical con-
cern about the utility of autopsy-derived tissue and how
representative it is of physiologic conditions, due to the of
the effect of PMI on tissue degradation. In this study we
specifically test the utility of devitalized cardiac tissue for
gene expression, obtained through both a cardiac explant
(failed heart) and a rapid-autopsy program (non-failed
heart). We systematically evaluate the variability of RNA
message in devitalized tissue in a time dependent manner
in an attempt to simulate general autopsy conditions.
Assessing the factors regulating RNA integrity is
important to determine the reliability of gene expression
patterns in cardiac tissue. Further, the existence of signif-
icant biological variability in expression levels of many
genes between human hearts is widely recognized. There-
fore, in this study we establish the extent of variation as a
consequence of autolysis, and secondarily, generate a
gene expression profile of a failing human heart.
Methods
Sample Collection
Cardiac tissue was obtained from an explanted failing
heart via cardiac transplantation and from a “normal”
heart through a metastatic cancer rapid-autopsy pro-
gram. This study was approved by the IRB of The Johns
Hopkins Hospital and all samples provided informed
consent. Total RNA was extracted from the tissues using
the RNeasy Fibrous Tissue Mini kit (Qiagen) according
to the manufacture’s protocol.
W eo b t a i n e dl e f ta n dr i g h tv e n t r i c l et i s s u eh a r v e s t e d
under conditions that simulated general autopsy condi-
tions. The baseline time-point (deemed the 0 hour time-
point) for the explanted failing heart was harvested within
1 hour of explantation, while the autopsy heart was har-
vested 3-4 hours after the patient died. After rapidly col-
lecting an initial 0 hour time-point to establish a baseline
measure of gene expression, the hearts were placed in a
37°C incubator that was then turned off and allowed to
cool at ~1°C/hr to reach room temperature ~12 hours
later. After reaching ambient temperature, 6 heart samples
were further cooled to 4°C (cold-24 hour autolysis) and
9 were left at room temperature (warm-24 hour autolysis).
These two conditions represent two alternate scenarios of
tissue harvesting. The first scenario simulates an autopsy
where a body may begin cooling to ambient temperature
for ~12 hours, before transportation and storage in a refri-
gerated room in a morgue which accelerates body cooling.
The second we consider a “worst case” scenario where the
body is not cooled. At each harvesting time point, tissue
was flash frozen in liquid nitrogen or placed in RNAlater
from the left and right ventricle free wall. Twenty tissue
samples were harvested from each heart at time points 0,
6, 12, 18 (cold and warm) and 24 (cold and warm) hours
( F i g u r e1 ) .T h eR N AI n t e g r i t yn u m b e r s( R I N )o fa l lt h e
20 samples were obtained from the Agilent Bioanalyzer
2100 to assess the RNA quality of the samples [13]. Gene
expression profiles were determined at time points 0, 6,
12, 18 and 24 hours in 13 tissue samples harvested from
the autopsy heart. Profiles were obtained at time points 0,
6, 12, 18 hours in 7 tissue samples from the explant heart.
Microarray Expression Analysis
RNA from the 20 samples, along with a HeLa control run
in triplicate, were run on the Affymetrix Exon arrays
according to the manufacturer’sp r o t o c o l .A r r a yd a t af o r
this study has been deposited in the National Center for
Biotechnology Information’s Gene Expression Omnibus
(GEO) with accession number GSE32519. Exon arrays
have 1.4 million probesets that map to over a million
exon clusters. These feature probesets target each tran-
script throughout, rather than simply at the 3’ end,
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Figure 1 Simulated autopsy conditions. All heart samples were
initially placed in a 37°C incubator that was then turned off and
allowed to cool ~1°C/hr to reach room temperature ~12 hours later.
Thereafter, to simulate cold and warm-24 hour autolysis tissue
harvesting conditions, some hearts were cooled at 2-3°C/hr (to 4°C)
(blue line) and others were left at room temperature (red line).
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expressed genes [14]. We analyzed expression data from
~200,000 core probesets that are supported by putative
mRNAs from the RefSeq database. Signal processing was
performed after quantile normalization and median pol-
ish summarization of the PM (Perfect Match) probes by
using the Affymetrix power tools and the Robust Multi-
Array Analysis (RMA) algorithm [15]. Probes with low
p values (p < 0.05) have signals that are distinct from
background and are considered to be detected above
background (DABG). After filtering to retain probes
flagged as present (DABG < 0.05) in at least one-fourth
of the samples, 162,145 probes remained, which mapped
to ~15,000 transcripts. Exon-based and intron-based pro-
besets from putative housekeeping genes serve as positive
and negative control sets, respectively. These signals are
used to produce an “area under the curve” (AUC) value
in a receiver-operating characteristic (ROC) curve as a
measure of separation between the positive and negative
controls, which is indicative of the quality of hybridiza-
tion [16]
GNF Expression Atlas 2 [17] allows for the classifica-
tion of genes depending on their expression in the 79
human organs and tissues covered by the Atlas. Approxi-
mately, 8,400 genes expressed in the heart in the GNF
Expression Atlas were downloaded via the Biomart tool.
Statistical Analysis
All statistical analysis was performed using R (version
2.9.2). Principal component analysis was performed using
the function “prcomp” in the “stats” package of R. Two-
class Significance Analysis of Microarrays (SAM) [18] was
used to identify genes that were differentially expressed,
which is implemented as the “samr” package in R. SAM
calculates the test statistic for relative difference in gene
expression based on permutation analysis of expression
data and calculates a false discovery rate, which gives the
proportion of significant genes most likely identified by
chance. We used the two class unpaired test statistic in
SAM. The two class unpaired test is similar to a between
subjects t-tests wherein mean expressions in two groups
are determined significant based on the calculated statistic,
d, from the original and permuted data for each gene. In
this study a false discovery rate (FDR; q < 5%) was used to
determine the differential genes between the two classes.
Functional Analysis
Genes were functionally annotated and classified by using
the functional annotation tool of database for annotation,
visualization, and integrat e dd i s c o v e r y( D A V I D )[ 1 9 ] .
The annotations were selected from Gene Ontology’s
“biological process”. The annotations have been selected
based on medium stringency (default) setting, with > 2-
fold enrichment and Benjamini-Hochberg p-value < 0.05.
The fold enrichment for a particular functional category
describes the ratio between the number of genes in the
gene list belonging to that category and the total number
of genes in the gene list, which has at least one functional
annotation. This ratio is then compared to the ratio
between the total number of genes in that category and
the total number of genes in the human genome with at
least one functional annotation. It has been observed that
it can be difficult to come up with a clear picture of gene
function given all the Gene Ontology (GO) terms anno-
tating the genes. Therefore, all the significantly enriched
GO categories were assigned their corresponding parent
GO Slim annotation. The GO Slims are reduced versions
of GO containing high-level, broader parent terms in the
whole GO [20] (http://www.geneontology.org/GO.slims.
shtml). This is feasible with GO because of the hierarchi-
cal parent and child relationships recorded between the
terms. Note that we only use the GO Slim terms of biolo-
gical process.
Results and Discussion
We obtained the expression profiles of 7 cardiac tissue
samples from the cardiac transplant operation (explant/
failed heart) and 13 from a rapid-autopsy program
(autopsy/non-failed heart) harvested under the “cold-”
and “warm-24 hour autolysis” conditions (Figure 1). The
left and right ventricular tissues showed highly corre-
lated gene expression in both the heart samples (Pear-
son’s coefficient, r > 0.94), and we therefore analyzed
the heart regions together. To assess the expression
array performance for each sample, we used the ROC
AUC summarization score, which is a measure of over-
all sensitivity and specificity of the expression profile.
The AUC scores for the 20 gene expression profiles har-
vested at increasing autolysis delay all ranged from 0.80
to 0.90, which is within the parameters suggested by
Affymetrix [16]. While RIN values are typically used to
predict sample performance, we only observed a weak
correlation between RIN values and ROC AUC (r
2 =
0.27, Figure 2), and note that even samples with RIN
values as low as 2.7 displayed robust hybridization. The
means of the RIN values in the “warm” and “cold” 24
hour autolysis samples were 5.1 (SD = 1.5) and 6.9 (SD
= 1.5), respectively, though this difference was not statis-
tically significant (P = 0.11) (Additional File 1, Figure
S1). We further observed that the RIN values were inde-
pendent of the autolysis time (r
2 =0 . 0 0 2 ,F i g u r e3 ) .
While this observation is based on a small dataset and is
at odds with many, but not all, reports of RIN quality
correlating with post mortem interval [21], we note that
in our analyses, RIN was not a strong predictor of array
performance.
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As an additional general test of expression array perfor-
mance with autolysed tissue, we used principal compo-
nent analysis (PCA) of gene intensities to cluster the 20
autopsy and explant heart samples, along with Hela con-
trols run in triplicate, as well as reference liver and heart
data obtained from Affymetrix. Irrespective of the time
and temperature of tissue harvest, the expression pro-
files of the two hearts could clearly be differentiated
from non-heart tissues, as observed by the PCA analysis
of ~15,000 gene intensities (Figure 4). In Figure 5, we
demonstrate that there is a strong correlation between
the baseline explant and autopsy hearts compared to
their later timepoints (Pearson’s correlation ranges from
0.92-0.98). As a comparison, the Pearson’s correlation(r),
between any two HeLa controls (technical replicates)
was 0.98. Additionally, the Pearson’s coefficient for
HeLa controls and reference liver with respect to a high
RIN heart (RIN = 8.6) was 0.65 and 0.66, respectively.
The concordance in expression profiles in autopsy tissue
was also investigated by pair-wise comparisons of all car-
diac expressed genes, expressed as the fold change
between time-points, (Figure 6). Specifically, 8,400 genes
expressed in the cardiac tissue were retrieved from GNF
Expression Atlas 2, which summarizes the expression pat-
terns of human, mouse and rat genes in several selected
tissues using whole-genome microarray experiments. To
establish a baseline level of expected concordance for tech-
nical replicates, we compared expression profile of two
HeLa controls, and observed 94.9% of genes with ≤1.25
fold change in expression (red line, Figure 6). The baseline
explant and autopsy and their later timepoints, showed
similar concordance in expression and we saw no differ-
ence from technical replicates (95.9% and 93.4% genes
with ≤1.25 fold change, respectively) (purple and brown
lines, Figure 6). We observed a difference between the
autopsy and explant expression profiles, with only 86.8%
genes with ≤1.25 fold change (black line, Figure 6). Com-
paring, either heart sample to the HeLa controls demon-
strated a striking difference in expression, with only 48%
with ≤1.25 fold change (green and blue lines, Figure 6).
Thus, global gene expression analysis suggests that RNA
expression is reproducible over 24 hours of autolysis and
we could distinguish between heart and non-heart
samples.
Autolysis Fluctuations of Gene Expression
After, establishing that global expression is largely unaf-
fected by autolysis interval, we looked at the small frac-
tion of genes that were sensitive to autolysis conditions.
We selected transcripts with > 2 fold-change (2-FC)
between the baseline and later timepoints from each
heart to evaluate the change in gene expression during
the 24 hours of autolysis in a time dependent manner.
For this analysis, we focused on the “cold-24 h autoly-
sis”, as this represents a typical autopsy scenario. Only
2.25% (345/15320) of transcripts from the autopsy
hearts had a > 2-FC when we compared the transcript
levels from the 4 later time-points (6, 12, 18, 24) to the
baseline levels. We queried these genes in the DAVID
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Figure 2 RNA quality and hybridization performance.T h eR I N
number, a measure of RNA quality, ranged from 2.7-8.6 in the heart
samples. The ROC AUC, a hybridization quality metric, ranged from
0.80 to 0.90, which is within the parameters suggested by
Affymetrix. All samples showed robust hybridization irrespective of
their RIN values (r
2 = 0.27).
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Figure 3 Autolysis interval and RNA quality.T h ea u t o l y s i s
interval, which ranged from 0 to 24 hours, did not correlate with
RNA integrity, measured as RIN numbers (r
2 = 0.002).
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GO terms. Table 1, provides the functional categories
overrepresented with a > 2-fold enrichment, Benjamini-
Hochberg p-value < 0.05 and the broader parent GO
Slim term. There was significant overrepresentation of
GO terms which associated with two GO Slim cate-
gories 1) “cellular metabolism” (76/354) and 2)
“response to stimulus” (42/354).
W ep e r f o r m e das i m i l a re x p e r i m e n tw i t ht h e
explanted heart, to see which categories of genes fluctu-
ate in response to autolysis under the same conditions.
One percent (154/15320) of transcripts from the
explanted hearts had a > 2-FC, when we compared the
fold changes in the transcripts from the 3 later time-
points (6, 12, 18) to the baseline. Significantly overrepre-
sented functional categories from the DAVID annota-
tion database and the associated broader GO Slim
parent terms are shown in Table 2. In the explant heart
the significant enrichment of GO terms associated with
the “response to stimulus” category was observed anno-
tating 44/154 genes. Three other significant functional
categories were mapped to “circulatory system process”
(8/154), “development” (15/154) and “cell differentia-
tion” (27/154). Thus, the broad parent GO Slim term
“response to stimulus” was significantly overrepresented
in both the autopsy and explant hearts, including 21
genes in common (Additional File 2, Table S1), in this
analysis of variation in gene expression during 24 hours
of autolysis.
Gene Expression Profile for a Failing Heart
Having established that the global expression from the
individual cardiac tissues is reproducible during 24
hours of autolysis, we next compared the expression
profile of the ventricular cardiac tissue from the explant
(failing heart) and the autopsy (non-failing heart) by
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Figure 4 Principal component analysis (PCA) of heart and non-heart gene expression intensities. A scatterplot of the PC1 and PC2 from
the PCA analysis of gene intensities of ~15,000 transcripts from the 20 autopsy and explant heart samples, along with reference triplicate HeLa
controls and triplicate heart and liver data (obtained from Affymetrix), clearly separates the samples into heart and non-heart spaces.
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focused on the “cold-24 hour autolysis” heart samples,
as representative of real-world autopsy conditions. Gene
expression profiles from 8 autopsy and 5 explant heart
samples were analyzed with the SAM technique, which
identified ~480 differentially expressed (DE) transcripts
at > 2-FC and q-values < 0.5. The heatmap in Figure 7
demonstrates ~480 transcripts with > 2-FC expression
between the two groups with 374 up-regulated and 108
down-regulated transcripts in the explant/failed heart.
The list of ~480 genes differentially up- and down-regu-
lated between the explant and autopsy hearts are given
in the Additional File 3, Table S2. The results were
unchanged after exclusion of the samples harvested at
the baseline 0 hour time-point.
Clinical evidence clearly demonstrates the dynamic nat-
ure of the components of the extracellular matrix in
response to mechanical unloading of the failing heart
[22,23] and a quantitative increase in collagen subtypes
[24]. We identified ECM proteins collagen I alpha 1
(COL1A1), collagen III alpha 1 (COL3A1) and fibronectin
(FN1) to be upregulated > 2-FC in the failing heart. Impor-
tantly, we identified natriuretic peptide A (NPPA)w h i c h
was 11-fold higher in the failing heart. NPPA is part of a
conserved adaptive change in molecular phenotype in
response to heart failure and serves as both a diagnostic
and potential therapeutic marker [25,26]. Recently, higher
than normal levels of osteoglycin (OGN, 12-fold increase
in the failing heart) were associated with the heart becom-
ing enlarged in rats and mice and in humans [27]. Perios-
tin, (POSTN, 8-fold increase in the failing heart) has also
been implicated in cardiac remodeling and therefore heart
failure [28]. Additionally, the expression of connective tis-
sue growth factor (CTGF, 4 fold change), transforming
growth factor-beta (TGFB2,3 . 1 8f o l dc h a n g e ) ,b r a i n
natriuretic peptide precursor (NPPB,2 . 2 9f o l dc h a n g e ) ,
Mu-crystallin (CRYM, 2.8 fold change) and clusterin
(CLU, 2.5 fold change), were all elevated in the failing
heart, consistent with previous reports [29-34]. The
expression of Alpha-1-antichymotrypsin (SERPINA3), a
known protease inhibitor, responsible for degradation or
disassembly of myocardial proteins, was down regulated in
the failing heart when compared to the non-failing heart
(8 fold decrease), which is consistent with the report by
Yang et al [35].
We also queried with the DAVID database to look for
enrichment of functions from GO biological processes
represented by the DE genes. The significantly over-repre-
sented functional annotations (> 2-fold enrichment and
Benjamini-Hochberg p-value < 0.05) and the associated
GO Slim terms are listed in Tables 3 and 4. Seventy-nine
of the 374 up-regulated genes in the failing heart were
a. 
b. 
c. 
Figure 5 Correlation between baseline and autolyzed gene expression. a and b. Scatterplots of expression intensity later time-points (x-
axis) and the 0 hour time-point (y-axis) for (a) autopsy and (b) explant heart tissues. Red lines represent the linear regression line indicating
relationship between expression profiles. Pearson’s correlation (r), between the baseline and later timepoints, range from 0.92-0.98. c. Scatterplot
of expression intensities between two technical replicates (HeLa Controls) with Pearson’s correlation, (r) of 0.98.
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Figure 6 Concordance in expression profiles in heart tissues. Pair-wise comparisons of all cardiac expressed genes (~8,400 based on the
GNF anatomical system data: heart), expressed as the fold change between time-points. To establish a baseline level of expected concordance
for technical replicates, we compared the expression profile of two HeLa controls, and observed 94.9% of genes with ≤1.25 fold change (red
line). Comparing the baseline explant and autopsy to later timepoints, we saw no difference from technical replicates (95.9% and 93.4% ≤1.25
fold change, respectively) (purple and brown lines). However, comparing the autopsy to the explant, we saw a measurable difference (86.8%
≤1.25 fold change) (black line), and comparing either heart sample to the HeLa controls demonstrated a striking difference (48% ≤1.25 fold
change) (green and blue lines).
Table 1 Annotations overrepresented in 2.25% genes fluctuating in the autopsy (non-failed) heart
Term
a GO Gene Count GO Slim GO Slim Gene Count
response to external stimulus 42
response to wounding 27 response to stimulus 42
inflammatory response 19
lipid metabolic process 41
organic acid metabolic process 33
carboxylic acid metabolic process 33
oxoacid metabolic process 33
cellular lipid metabolic process 30
fatty acid metabolic process 16
oxidation reduction 31
alcohol metabolic process 22 cellular metabolism 76
energy derivation by oxidation of organic compounds 12
carbohydrate biosynthetic process 10
generation of precursor metabolites and energy 18
monocarboxylic acid metabolic process 25
cellular ketone metabolic process 33
aAll functional annotations are significantly overrepresented with > 2-Fold Enrichment and Benjamini-Hochberg p-value < 0.05
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Page 7 of 12Table 2 Annotations overrepresented in 1% genes fluctuating in the explant (failed) heart
Term
a GO Gene Count GO Slim GO Slim Gene Count
circulatory system process 8 circulatory system process 8
response to external stimulus 23
regulation of defense response 9
regulation of response to stimulus 15
response to chemical stimulus 26
regulation of inflammatory response 7
response to cytokine stimulus 7
response to corticosteroid stimulus 7
response to organic substance 18
response to extracellular stimulus 10
response to mechanical stimulus 6
response to endogenous stimulus 13
response to stress 29
response to inorganic substance 9 response to stimulus 44
regulation of response to external stimulus 8
response to drug 9
response to glucocorticoid stimulus 6
response to lipopolysaccharide 6
regulation of response to stress 10
response to molecule of bacterial origin 6
response to hormone stimulus 11
response to steroid hormone stimulus 8
response to nutrient levels 8
response to bacterium 8
transforming growth factor beta receptor signaling pathway 5
skeletal system development 15 development cell 15
cell differentiation 27 differentiation 27
aAll functional annotations are significantly overrepresented with > 2-Fold Enrichment and Benjamini-Hochberg p-value < 0.05
Non-Failed heart  Failed Heart 
Figure 7 Differential gene expression. Heatmap of transcripts with > 2 fold change in expression between the failing and non-failing heart;
374 genes are up-regulated and 108 down-regulated. (red = up-regulated, and green = down-regulated)
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Page 8 of 12annotated into overlapping overrepresented GO functional
categories, with the associated GO slim terms “cellular
metabolism” and “response to stimulus” annotated for 29/
374 and 23/374 genes, respectively (Table 3). Fifty-nine of
the 108 down-regulated genes belonged to overlapping
functionally overrepresented GO categories which related
to parent GO Slim terms “response to stimulus” (49/108),
“regulation of biological quality” (23/108), “cellular pro-
cess” (9/108), and “transport” (5/108) (Table 4). Given that
we observed an enrichment of genes involved in “response
to stimulus” in the analysis of genes that fluctuate during
autolysis, we investigated whether the ~480 DE genes
between the failing and non-failing heart included genes
identified as fluctuating during autolysis. We observed
that 13% of the DE genes showed temporal fluctuation in
the autopsy hearts, while 9% showed fluctuation in the
explants, including important marker genes like NPPA,
NPPB and POSTN. We explored how fluctuation of these
genes during autolysis influenced the comparison of gene
expression between failed and non-failed heart. In all three
cases, these genes were clearly able to distinguish failed
from non-failed heart at all time points, with the exception
of NPPB at the 12 hr timepoint (Figure 8). Thus, despite >
2FC fluctuations in temporal expression in some impor-
tant genes due to autolysis, it is still possible to clearly
identify specific and relevant differentially expressed genes
in autolyzed cardiac tissue.
Conclusion
In this study we investigated the gene expression of car-
diac tissues in a simulated autopsy experiment. We
allowed the heart tissue to autolyze for 24 hours, either
Table 3 Annotations overrepresented in the up-regulated genes in the explant (failed) heart
Term
a GO Gene Count GO Slim GO Slim
Gene
Count
cellular ketone metabolic process 29 cellular metabolism 29
extracellular structure organization 15 extracellular structure organization and biogenesis 15
muscle contraction 12 muscle system process 12
regulation of cell adhesion 13 regulation of biological process 13
enzyme linked receptor protein signaling pathway 23 response to stimulus 23
aAll functional annotations are significantly overrepresented with > 2-Fold Enrichment and Benjamini-Hochberg p-value < 0.05
Table 4 Annotations overrepresented in the down-regulated genes in the explant (failed) heart
Term
a GO Gene Count GO Slim GO Slim Gene Count
cellular ion homeostasis 9 cellular process 9
regulation of biological quality 27 regulation of biological quality 27
defense response 22
response to stimulus 48
response to chemical stimulus 22
immune system process 19
response to stress 34
immune response 14
regulation of response to stimulus 12
response to external stimulus 26
response to bacterium 7
response to wounding 20 response to stimulus 49
regulation of immune response 9
regulation of defense response 7
inflammatory response 16
blood coagulation 6
innate immune response 10
positive regulation of defense 5
response 9
humoral immune response 6
complement activation, classical pathway
transition metal ion transport 5 transport 5
aAll functional annotations are significantly overrepresented with > 2-Fold Enrichment and Benjamini-Hochberg p-value < 0.05
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W ec h o s eal i m i to f2 4h o u r sa sw eh a v es h o w np r e -
viously that protein expression remains intact for 24
hours by immunohistochemistry, but degradation is
noticeable at 48 hours [36]. Thus our findings are
applicable to a 24 hour time course and we cannot spec-
ulate on late harvesting. We note that, in our experi-
ence, 24 hours is a reasonable amount of time to
conduct a standard autopsy and is well within the time
achievable by organ procurement organizations (OPOs)
[37]. The vast majority of genes expressed are stable
despite extended autolysis and reduced RNA integrity,
indicating that multiple-probe based exon arrays are
suited to reliably determine gene expression profiles.
We found that most molecular processes are not subject
to variation due to tissue procurement time and/or tis-
sue storage temperature. Global expression analysis sug-
gests that RNA expression is reproducible over 24 hours
of autolysis with 95% genes showing < 1.2 fold change.
As a proof of principle, we used SAM analysis to iden-
tify a list of 480 differentially expressed genes, including
several types of collagens, lumican (LUM), natriuretic
peptide A (NPPA) and connective tissue growth factor
(CTGF), which allow for the clear separation between
the failing and non-failing heart expression profiles -
irrespective of autolysis time.
a. b. 
c. 
Figure 8 Differentially expressed and fluctuating genes. Expression profile of (a) NPPA, (b) NPPB and (c) POSTN genes in the failing and non-
failing hearts. The genes are differentially expressed and show fluctuation in expression in the failed heart.
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autolysis has relatively minor effects on RNA integrity.
Only a small fraction (< 2.5%) of transcripts fluctuate
over the 24 hours of autolysis, enriched in functional
categories (energy metabolism, immune and signal
responses) that are known to be the most adaptable and
responsive biological processes and often highly variable
between biological specimens [38]. Thus, our results
demonstrate that RNA from autopsy-derived tissue,
even up to 24 hours of autolysis, can be used to identify
biologically relevant expression pattern differences, ser-
ving as a practical source for gene expression and eQTL
experiments.
Additional material
Additional file 1: Figure S1: RIN range in “warm- and “cold-24 hour
autolysis” samples. The range of the RIN values in the warm-24
autolysis samples was 2.7 - 8.6, while the range in the cold- 24 autolysis
samples was 3.5 - 8.6. The means of the RIN values in the “warm” and
“cold” 24 hour autolysis samples were 5.1 (SD 1.53) and 6.9 (SD 1.45),
respectively, and this difference was not statistically significant (P = 0.11).
Additional file 2: Table S1: Postmortem fluctuating genes common
in autopsy and explant hearts. The gene symbol and description of
the 21 genes, which showed variation in gene expression during 24
hours of autolysis in both the autopsy and explant hearts.
Additional file 3: Table S2: List of 374 upregulated (Table S2a)and
108 downregulated (Table S2b) genes in the explant/failed heart.
List of ~480 genes differentially up- and down-regulated between the
explant and autopsy hearts. Among these differentially expressed genes,
374 genes were upregulated and 108 genes were downregulated in the
explant/failed heart.
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